Nicholas A. Smith

Array ( [id] => 860671 [patent_doc_number] => 07371825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Anti-MCP-1 antibodies, compositions, methods and uses' [patent_app_type] => utility [patent_app_number] => 11/170453 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 39680 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371825.pdf [firstpage_image] =>[orig_patent_app_number] => 11170453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966485 [patent_doc_number] => 20050233382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Polypeptide variants with altered effector function' [patent_app_type] => utility [patent_app_number] => 11/158839 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 40227 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233382.pdf [firstpage_image] =>[orig_patent_app_number] => 11158839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080158 [patent_doc_number] => 20110142858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Method of Passsive Immunization Against Disease or Disorder Charcterized by Amyloid Aggregation with Diminished Risk of Neuroinflammation' [patent_app_type] => utility [patent_app_number] => 11/628720 [patent_app_country] => US [patent_app_date] => 2005-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10639 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142858.pdf [firstpage_image] =>[orig_patent_app_number] => 11628720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 853119 [patent_doc_number] => 07378504 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Human monoclonal antibodies to Fc gamma receptor I (CD64)' [patent_app_type] => utility [patent_app_number] => 11/145001 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 29647 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378504.pdf [firstpage_image] =>[orig_patent_app_number] => 11145001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835593 [patent_doc_number] => 20060247425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Glycosylated immunoglobulin and immunoadhesin comprising the same' [patent_app_type] => utility [patent_app_number] => 10/555538 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9873 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247425.pdf [firstpage_image] =>[orig_patent_app_number] => 10555538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5624862 [patent_doc_number] => 20060263367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Bispecific antibody devoid of Fc region and method of treatment using same' [patent_app_type] => utility [patent_app_number] => 11/136096 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11104 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263367.pdf [firstpage_image] =>[orig_patent_app_number] => 11136096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 221138 [patent_doc_number] => 07608684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'Soluble CD14 antigen' [patent_app_type] => utility [patent_app_number] => 11/126344 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 58196 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608684.pdf [firstpage_image] =>[orig_patent_app_number] => 11126344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7251662 [patent_doc_number] => 20050272916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Method of modulating the activity of functional immune molecules' [patent_app_type] => utility [patent_app_number] => 11/126299 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24028 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272916.pdf [firstpage_image] =>[orig_patent_app_number] => 11126299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201558 [patent_doc_number] => 08188231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Optimized FC variants' [patent_app_type] => utility [patent_app_number] => 11/124620 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 73 [patent_no_of_words] => 58438 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188231.pdf [firstpage_image] =>[orig_patent_app_number] => 11124620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201558 [patent_doc_number] => 08188231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Optimized FC variants' [patent_app_type] => utility [patent_app_number] => 11/124620 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 73 [patent_no_of_words] => 58438 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188231.pdf [firstpage_image] =>[orig_patent_app_number] => 11124620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216862 [patent_doc_number] => 20050260213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Fcgamma-RIIB-specific antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/108135 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 78397 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260213.pdf [firstpage_image] =>[orig_patent_app_number] => 11108135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886419 [patent_doc_number] => 20080260751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Methods and Compositions for the Modulation of Immune Responses and Autoimmune Diseases' [patent_app_type] => utility [patent_app_number] => 10/599797 [patent_app_country] => US [patent_app_date] => 2005-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 18818 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260751.pdf [firstpage_image] =>[orig_patent_app_number] => 10599797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 869064 [patent_doc_number] => 07365168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis' [patent_app_type] => utility [patent_app_number] => 11/102621 [patent_app_country] => US [patent_app_date] => 2005-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 26 [patent_no_of_words] => 46717 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365168.pdf [firstpage_image] =>[orig_patent_app_number] => 11102621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769506 [patent_doc_number] => 20050266008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Human anti-IRTA-5 antibodies' [patent_app_type] => utility [patent_app_number] => 11/093274 [patent_app_country] => US [patent_app_date] => 2005-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 29939 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266008.pdf [firstpage_image] =>[orig_patent_app_number] => 11093274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069020 [patent_doc_number] => 20050244403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Immunoglobulin variants outside the Fc region' [patent_app_type] => utility [patent_app_number] => 11/090981 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 29734 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244403.pdf [firstpage_image] =>[orig_patent_app_number] => 11090981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7039355 [patent_doc_number] => 20050158789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/074646 [patent_app_country] => US [patent_app_date] => 2005-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 19042 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158789.pdf [firstpage_image] =>[orig_patent_app_number] => 11074646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250201 [patent_doc_number] => 20050142141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Delivery of enzymes to the brain' [patent_app_type] => utility [patent_app_number] => 11/061956 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18189 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142141.pdf [firstpage_image] =>[orig_patent_app_number] => 11061956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7967051 [patent_doc_number] => 07939635 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy' [patent_app_type] => utility [patent_app_number] => 11/060102 [patent_app_country] => US [patent_app_date] => 2005-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 23 [patent_no_of_words] => 13149 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939635.pdf [firstpage_image] =>[orig_patent_app_number] => 11060102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250097 [patent_doc_number] => 20050142127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/044015 [patent_app_country] => US [patent_app_date] => 2005-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 102 [patent_figures_cnt] => 102 [patent_no_of_words] => 19569 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142127.pdf [firstpage_image] =>[orig_patent_app_number] => 11044015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4513393 [patent_doc_number] => 07931895 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Monoclonal antibodies with enhanced ADCC function' [patent_app_type] => utility [patent_app_number] => 11/039877 [patent_app_country] => US [patent_app_date] => 2005-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 11608 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/931/07931895.pdf [firstpage_image] =>[orig_patent_app_number] => 11039877 [rel_patent_id] =>[rel_patent_doc_number] =>)